“
Moderna was the most hated biotech stock before COVID. No revenue. No products. Billions in losses. Short sellers loved us. Then we made the vaccine that ended the pandemic and became a $100 billion company.
Moderna was the most hated biotech stock before COVID. No revenue. No products. Billions in losses. Short sellers loved us. Then we made the vaccine that ended the pandemic and became a $100 billion company.